| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | Canada | 2 | |
| #4 | China | 2 | |
| #5 | Israel | 1 | |
| #6 | New Zealand | 1 | |
| #7 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Microorganisms | |
| #5 | Measuring microorganism processes | |
| #6 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Sidenius Nicolai | 11 |
| #2 | Gandhi Sonu | 4 |
| #3 | Nicassio Francesco | 3 |
| #4 | Bianchi Fabrizio | 3 |
| #5 | Di Fiore Pier Paolo | 2 |
| #6 | Rossiello Francesca | 1 |
| #7 | Costanzo Vincenzo | 1 |
| #8 | De Lorenzi Valentina | 1 |
| #9 | Vecchi Manuela | 1 |
| #10 | Lampugnani Maria Grazia | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2015140005A1 | Method of generation of pluripotent cells | |
| WO2015004148A1 | Biomarker of plasminogen activation system and/or of upar/vn interaction and uses thereof | |
| CA2842281A1 | Constitutively active upar variants and their use for the generation and isolation of inhibitory antibodies | |
| EP2505663A1 | A method to identify asymptomatic high-risk individuals with early stage lung cancer by means of detecting miRNAs in biologic fluids |